24 results
CORRESP
CPHI
China Pharma Holdings Inc.
8 Sep 23
Correspondence with SEC
12:00am
dysfunction caused by acute and chronic hepatitis; supplemental treatment to toxic/trauma hepatitis, liver cancer; also for the indication of food/drug
8-K
EX-2.1
fpv768f901pr556ee 76
20 Oct 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cso4jyl
11 May 05
Unregistered Sales of Equity Securities
12:00am
PRER14C
9qz9ych6d
8 Dec 03
Preliminary revised information
12:00am